NCT03346772View on ClinicalTrials.gov

Study of Immune Responses to Influenza Vaccination

PHASE4RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 20, 2017

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions
Influenza Vaccination
Interventions
BIOLOGICAL

Influenza vaccination

Adults will receive one intramuscular dose of seasonal quadrivalent inactivated influenza vaccine, as indicated for standard of care.

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER